Sektor Mayinglong Pharmaceutical Group Co., LTD.

Aktien

A0M4N8

CNE000001HN2

600993

Pharmazeutika

Schlusskurs 26.10.2026 Perf. 5 T Veränd. 1. Jan.
24.33 CNY +0.16% Intraday Chart für Mayinglong Pharmaceutical Group Co., LTD. -2.33% -13.11%
Hauptkonkurrenten
% % 5 Tage Veränd. 1 Monat Veränd. 3 Monate % 1. Jan. Perf. 1 Jahr Perf. 3 Jahre Veränd. 5 Jahre Veränd. 10 Jahre Marktkap.($)
+0.16%-2.33%+9.84%+5.05%-13.11%-12.73%+10.64%-8.47%+14.06% 1.57 Mrd.
+0.45%+3.13%+8.08%+6.95%+19.03%+54.96%+125.16%+414.87%+1’566.41% 1’135 Mrd.
+0.94%+4.93%-1.81%+1.10%+28.68%+39.86%+78.72%+60.66%+132.45% 635 Mrd.
+0.39%+1.44%+8.47%+10.56%+25.49%+25.77%+97.48%+161.89%+369.91% 505 Mrd.
+1.43%+4.31%+10.05%+11.66%+20.81%+46.20%+67.12%+10.77%+75.06% 378 Mrd.
-3.21%-2.10%-5.49%+7.28%+33.58%+60.72%+33.22%+70.95%+131.00% 358 Mrd.
-0.41%+2.64%+6.41%+0.46%+16.31%+22.48%+49.82%+63.71%+79.04% 295 Mrd.
+0.23%+3.66%+2.41%+1.45%-6.79%+2.57%+23.69%+42.77%+169.08% 266 Mrd.
+1.22%+4.63%+7.24%+18.24%+35.84%+52.40%+64.85%+113.07%+179.66% 237 Mrd.
+1.70%+3.67%+5.14%+22.72%+29.29%+31.21%+102.15%+134.30%+110.52% 193 Mrd.
+0.12%+1.54%+2.94%-18.76%-19.92%-23.87%-61.50%-24.02%+89.42% 172 Mrd.
-0.80%+1.19%+3.91%+21.39%+19.64%+20.32%-4.40%-31.61%-8.06% 171 Mrd.
-1.23%+3.10%-1.65%+8.41%+14.15%+22.81%+43.24%+181.14%+557.46% 133 Mrd.
+0.21%+4.73%-1.99%-0.77%+14.22%+40.57%+16.31%+5.79%+24.99% 126 Mrd.
-0.79%-1.74%+14.57%+18.07%+21.04%+23.85%+119.84%+377.41%+526.14% 117 Mrd.
+1.11%+3.23%+3.46%-0.23%+4.96%+18.21%+29.88%+6.82%-5.81% 102 Mrd.
+0.62%+5.03%+3.89%-1.91%-9.84%-16.00%-25.76%-12.92%+9.50% 99.44 Mrd.
+0.33%+3.28%+2.49%+23.12%+4.64%+39.75%+1.98%+36.40%+122.45% 80.39 Mrd.
-0.62%-12.36%-0.02%+267.76%+574.30%+643.64%+161.71%-42.49% - 79.89 Mrd.
-2.07%+5.01%+6.13%-1.40%-18.09%-0.52%+51.12%+57.02%+482.07% 71.3 Mrd.
Durchschnitt +0.04%+1.41%+4.20%+20.06%+39.71%+54.61%+49.26%+80.90%+243.44% 257.82 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt +0.30%+1.60%+4.49%+10.99%+27.21%+44.77%+70.28%+148.54%+483.36%
  1. Börse
  2. Aktien
  3. A0M4N8 Aktie
  4. Sektor Mayinglong Pharmaceutical Group Co., LTD.